A treatment for HIV taken just once, using the genome-editing technology Crispr, is receiving fast-track designation from the U.S. Food and Drug Administration. . . . → Read More: One-Time Crispr HIV Therapy Given Fast-Track Status
|
|||||
       |
 Comments are closed  New products, Regulations  biomedical, biotechnology, chemistry, clinical trials, FDA, genomics, health care, HIV, licensing, life sciences, pharmaceuticals, physical sciences, university 
A synthetic biology company is receiving a contract with the U.S. advanced defense research agency to devise a high-speed localized process for making therapeutic proteins. . . . → Read More: Darpa Seeking On-Demand, Distributed Production of Proteins Comments are closed Joint ventures/collaborations, New products biomedical, biotechnology, chemistry, contract, DoD, engineering, genomics, life sciences, manufacturing, mathematics, pharmaceuticals, physical sciences, U.K., university 
A process for delivering nutrients for crop growth that its developers say is more sustainable than most fertilizer methods today received a U.S. patent. . . . → Read More: Bio-Friendly Plant Nutrient Delivery Patent Awarded Comments are closed Intellectual property agriculture, biotechnology, Canada, chemistry, engineering, life sciences, patent, physical sciences, USPTO 
A company using a process it says can produce synthetic genes with greater accuracy for research and clinical applications is raising $10 million in its first venture round. . . . → Read More: Synthetic DNA Company Gains $10M in Venture Round Comments are closed Finance, New products biomedical, biotechnology, chemistry, engineering, entrepreneurs, equity, genomics, investment, life sciences, mathematics, pharmaceuticals, physical sciences, U.K., venture capital 
A bioengineering lab created a system to make it easier for life scientists to use machine learning for data analysis, without writing their own algorithms. . . . → Read More: Automated Life Science A.I. Generation System Unveiled Comments are closed New products biomedical, biotechnology, chemistry, computer science, engineering, life sciences, mathematics, physical sciences, software, university 
A new U.S. patent, licensed to a start-up biotechnology company, describes processes for linking together chains of synthetic peptides into therapeutic proteins. . . . → Read More: Patent Issued for Synthetic Peptide Chain Techniques One comment - (Comments are closed) Intellectual property biomedical, biotechnology, chemistry, engineering, entrepreneurs, genomics, licensing, life sciences, materials science, patent, pharmaceuticals, physical sciences, university, USPTO 
A new biotechnology company is advancing research to find a comprehensive treatment for cystic fibrosis, and staked to a €2 million seed investment from its founder. . . . → Read More: Biotech Start-Up to Discover Cystic Fibrosis Therapy Comments are closed Finance, Joint ventures/collaborations, New products biomedical, biotechnology, chemistry, entrepreneurs, equity, Europe, genomics, investment, life sciences, pharmaceuticals, physical sciences, preclinical, university, venture capital 
A biological testing device company and industrial graphene manufacturer are collaborating on large-scale production of graphene biosensors for widespread use. . . . → Read More: Partnership to Mass-Produce Graphene Biosensors One comment - (Comments are closed) Joint ventures/collaborations biomedical, biotechnology, chemistry, engineering, life sciences, manufacturing, materials science, medical device, physical sciences, physics 
A developer of nanoscale lipid particles for delivering genomic therapies to specific cells and tissue, spun-off from academic labs, is raising $25 million in seed funds. . . . → Read More: Targeted Genetic Nanoparticle Company Gains $25M in Seed Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, chemistry, engineering, entrepreneurs, equity, genomics, investment, licensing, life sciences, nanotechnology, pharmaceuticals, physical sciences, preclinical, university, venture capital 
A clinical trial is underway testing an experimental therapy for peanut allergy that its developer says trains the immune system without using peanut proteins. . . . → Read More: Clinical Trial Begins for Peanut Allergy Treatment Comments are closed New products Australia, biomedical, biotechnology, chemistry, clinical trials, life sciences, pharmaceuticals, physical sciences, university |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts